Free Trial
Ends Tomorrow! Last Chance to Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim $100 Off
Claim MarketBeat All Access Sale Promotion

AMN Healthcare Services (AMN) Competitors

AMN Healthcare Services logo
$27.65 +2.00 (+7.81%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$27.64 -0.02 (-0.07%)
As of 05/22/2026 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AMN vs. EYE, MEDP, VEEV, WST, and CRVL

Should you buy AMN Healthcare Services stock or one of its competitors? MarketBeat compares AMN Healthcare Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AMN Healthcare Services include National Vision (EYE), Medpace (MEDP), Veeva Systems (VEEV), West Pharmaceutical Services (WST), and CorVel (CRVL).

How does AMN Healthcare Services compare to National Vision?

National Vision (NASDAQ:EYE) and AMN Healthcare Services (NYSE:AMN) are related small-cap companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

In the previous week, National Vision and National Vision both had 3 articles in the media. National Vision's average media sentiment score of 1.02 beat AMN Healthcare Services' score of -0.25 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

National Vision has a net margin of 2.31% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.31% 6.41% 2.81%
AMN Healthcare Services -0.95%18.01%5.19%

99.2% of AMN Healthcare Services shares are owned by institutional investors. 2.4% of National Vision shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

National Vision has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.69$29.60M$0.5730.05
AMN Healthcare Services$2.73B0.39-$95.70M-$0.87N/A

National Vision has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market.

National Vision currently has a consensus price target of $30.08, indicating a potential upside of 75.62%. AMN Healthcare Services has a consensus price target of $25.29, indicating a potential downside of 8.56%. Given National Vision's stronger consensus rating and higher probable upside, equities research analysts plainly believe National Vision is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

Summary

National Vision beats AMN Healthcare Services on 11 of the 15 factors compared between the two stocks.

How does AMN Healthcare Services compare to Medpace?

Medpace (NASDAQ:MEDP) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Medpace has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.53B4.89$451.12M$15.9127.20
AMN Healthcare Services$2.73B0.39-$95.70M-$0.87N/A

Medpace has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market.

In the previous week, Medpace had 24 more articles in the media than AMN Healthcare Services. MarketBeat recorded 27 mentions for Medpace and 3 mentions for AMN Healthcare Services. Medpace's average media sentiment score of 0.25 beat AMN Healthcare Services' score of -0.25 indicating that Medpace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
4 Very Positive mention(s)
1 Positive mention(s)
22 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
AMN Healthcare Services
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

78.0% of Medpace shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 20.5% of Medpace shares are owned by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Medpace has a net margin of 17.19% compared to AMN Healthcare Services' net margin of -0.95%. Medpace's return on equity of 120.89% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace17.19% 120.89% 24.79%
AMN Healthcare Services -0.95%18.01%5.19%

Medpace currently has a consensus price target of $467.08, suggesting a potential upside of 7.92%. AMN Healthcare Services has a consensus price target of $25.29, suggesting a potential downside of 8.56%. Given Medpace's higher probable upside, research analysts clearly believe Medpace is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
1 Sell rating(s)
10 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.20
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

Summary

Medpace beats AMN Healthcare Services on 12 of the 15 factors compared between the two stocks.

How does AMN Healthcare Services compare to Veeva Systems?

AMN Healthcare Services (NYSE:AMN) and Veeva Systems (NYSE:VEEV) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 88.2% of Veeva Systems shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 10.6% of Veeva Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

AMN Healthcare Services has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market. Comparatively, Veeva Systems has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market.

In the previous week, Veeva Systems had 25 more articles in the media than AMN Healthcare Services. MarketBeat recorded 28 mentions for Veeva Systems and 3 mentions for AMN Healthcare Services. Veeva Systems' average media sentiment score of 0.89 beat AMN Healthcare Services' score of -0.25 indicating that Veeva Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Veeva Systems
15 Very Positive mention(s)
6 Positive mention(s)
3 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Veeva Systems has a net margin of 28.44% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Veeva Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services-0.95% 18.01% 5.19%
Veeva Systems 28.44%13.80%11.39%

AMN Healthcare Services currently has a consensus target price of $25.29, suggesting a potential downside of 8.56%. Veeva Systems has a consensus target price of $276.52, suggesting a potential upside of 72.39%. Given Veeva Systems' stronger consensus rating and higher probable upside, analysts plainly believe Veeva Systems is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22
Veeva Systems
1 Sell rating(s)
9 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.58

Veeva Systems has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Veeva Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.39-$95.70M-$0.87N/A
Veeva Systems$3.20B8.20$908.91M$5.4129.65

Summary

Veeva Systems beats AMN Healthcare Services on 14 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

West Pharmaceutical Services has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$3.07B7.28$493.70M$7.4842.36
AMN Healthcare Services$2.73B0.39-$95.70M-$0.87N/A

West Pharmaceutical Services presently has a consensus target price of $322.89, indicating a potential upside of 1.90%. AMN Healthcare Services has a consensus target price of $25.29, indicating a potential downside of 8.56%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, equities analysts clearly believe West Pharmaceutical Services is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
2.92
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

West Pharmaceutical Services has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market.

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, West Pharmaceutical Services had 12 more articles in the media than AMN Healthcare Services. MarketBeat recorded 15 mentions for West Pharmaceutical Services and 3 mentions for AMN Healthcare Services. West Pharmaceutical Services' average media sentiment score of 1.01 beat AMN Healthcare Services' score of -0.25 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
10 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

West Pharmaceutical Services has a net margin of 16.85% compared to AMN Healthcare Services' net margin of -0.95%. West Pharmaceutical Services' return on equity of 19.03% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services16.85% 19.03% 14.06%
AMN Healthcare Services -0.95%18.01%5.19%

Summary

West Pharmaceutical Services beats AMN Healthcare Services on 15 of the 17 factors compared between the two stocks.

How does AMN Healthcare Services compare to CorVel?

AMN Healthcare Services (NYSE:AMN) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by company insiders. Comparatively, 44.6% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

CorVel has a net margin of 11.51% compared to AMN Healthcare Services' net margin of -0.95%. CorVel's return on equity of 29.92% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services-0.95% 18.01% 5.19%
CorVel 11.51%29.92%17.68%

AMN Healthcare Services presently has a consensus price target of $25.29, indicating a potential downside of 8.56%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, analysts clearly believe AMN Healthcare Services is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22
CorVel
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

CorVel has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.39-$95.70M-$0.87N/A
CorVel$958.53M3.35$95.17M$2.1429.32

AMN Healthcare Services has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market. Comparatively, CorVel has a beta of 0.98, suggesting that its share price is 2% less volatile than the broader market.

In the previous week, CorVel had 8 more articles in the media than AMN Healthcare Services. MarketBeat recorded 11 mentions for CorVel and 3 mentions for AMN Healthcare Services. CorVel's average media sentiment score of 0.74 beat AMN Healthcare Services' score of -0.25 indicating that CorVel is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
CorVel
4 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

CorVel beats AMN Healthcare Services on 11 of the 16 factors compared between the two stocks.

Get AMN Healthcare Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMN vs. The Competition

MetricAMN Healthcare ServicesMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$1.07B$8.28B$6.44B$23.18B
Dividend YieldN/A2.98%2.76%4.10%
P/E Ratio-31.7921.2721.2630.65
Price / Sales0.3918.86552.9924.48
Price / Cash3.3384.4843.6825.10
Price / Book1.505.7710.364.74
Net Income-$95.70M$180.93M$3.56B$1.07B
7 Day Performance-3.25%59.84%5.12%1.95%
1 Month Performance36.15%49.57%3.54%0.66%
1 Year Performance33.07%4.96%34.14%28.43%

AMN Healthcare Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMN
AMN Healthcare Services
1.4875 of 5 stars
$27.65
+7.8%
$25.29
-8.6%
+33.1%$1.07B$2.73BN/A2,664
EYE
National Vision
4.4866 of 5 stars
$17.32
-0.7%
$30.08
+73.7%
-9.1%$1.40B$1.99B30.3913,138
MEDP
Medpace
2.8681 of 5 stars
$420.67
+1.3%
$467.08
+11.0%
+46.8%$11.86B$2.53B26.446,200
VEEV
Veeva Systems
4.822 of 5 stars
$163.98
+3.2%
$276.52
+68.6%
-31.3%$25.95B$3.20B30.317,928
WST
West Pharmaceutical Services
3.8334 of 5 stars
$304.31
+0.5%
$322.89
+6.1%
+54.1%$21.40B$3.07B40.6810,800

Related Companies and Tools


This page (NYSE:AMN) was last updated on 5/24/2026 by MarketBeat.com Staff.
From Our Partners